Mirk kinase inhibition targets ovarian cancer ascites
The Mirk/dyrk1B gene is commonly amplified or upregulated in ovarian cancers, and Mirk is an active kinase in these cancers. Mirk mediates cancer cell survival by decreasing toxic ROS levels through maintaining expression of a series of antioxidant genes, possibly through its transcriptional activat...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Impact Journals LLC
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104763/ |